CAC
COCH icon

Cowen and Company’s Envoy Medical COCH Stock Holding History

Cowen and Company’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-129,040
Closed -$1.32M – 652
2023
Q2 		$1.32M Buy
129,040
+4,040
+3% +$40.8K 0.11% 125
2023
Q1 		$1.26M Buy
125,000
+71,946
+136% +$721K 0.15% 83
2022
Q4 		$532K Buy
+53,054
New +$528K 0.06% 122

Other funds holding COCH

AMC
Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
RCM
Robinson Capital Management Grosse Pointe Farms, Michigan $239M AUM 0.62% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

Cowen and Company's COCH Position: Q3 2023 in Review

Cowen and Company sold out of Envoy Medical (COCH) in Q3 2023, closing a stake of 129,040 shares — an estimated $1.32M sold.

Cowen and Company first reported a position in COCH in Q4 2022 and held it in 3 quarters. The position peaked at $1.32M in Q2 2023. 16 funds tracked by Wall St. Rank hold COCH as of Q3 2023.

  • Cowen and Company reported no remaining Envoy Medical position as of Q3 2023 after selling out during the quarter.
  • Cowen and Company sold 129,040 Envoy Medical shares in Q3 2023, an estimated $1.32M.
  • Cowen and Company first reported a position in Envoy Medical in Q4 2022 and held it in 3 quarters.
  • Cowen and Company's Envoy Medical position peaked at $1.32M in Q2 2023.
  • 16 funds tracked by Wall St. Rank held Envoy Medical as of Q3 2023.

Based on Cowen and Company's 13F filing for Q3 2023, filed 9 Nov 2023.